Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.

Fish are an important model for the pharmacological and toxicological characterization of human pharmaceuticals in drug discovery, drug safety assessment and environmental toxicology. However, do fish respond to pharmaceuticals as humans do? To address this question, we provide a novel quantitative...

Full description

Bibliographic Details
Main Authors: Luigi Margiotta-Casaluci, Stewart F Owen, Rob I Cumming, Anna de Polo, Matthew J Winter, Grace H Panter, Mariann Rand-Weaver, John P Sumpter
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4206295?pdf=render
_version_ 1811259282130206720
author Luigi Margiotta-Casaluci
Stewart F Owen
Rob I Cumming
Anna de Polo
Matthew J Winter
Grace H Panter
Mariann Rand-Weaver
John P Sumpter
author_facet Luigi Margiotta-Casaluci
Stewart F Owen
Rob I Cumming
Anna de Polo
Matthew J Winter
Grace H Panter
Mariann Rand-Weaver
John P Sumpter
author_sort Luigi Margiotta-Casaluci
collection DOAJ
description Fish are an important model for the pharmacological and toxicological characterization of human pharmaceuticals in drug discovery, drug safety assessment and environmental toxicology. However, do fish respond to pharmaceuticals as humans do? To address this question, we provide a novel quantitative cross-species extrapolation approach (qCSE) based on the hypothesis that similar plasma concentrations of pharmaceuticals cause comparable target-mediated effects in both humans and fish at similar level of biological organization (Read-Across Hypothesis). To validate this hypothesis, the behavioural effects of the anti-depressant drug fluoxetine on the fish model fathead minnow (Pimephales promelas) were used as test case. Fish were exposed for 28 days to a range of measured water concentrations of fluoxetine (0.1, 1.0, 8.0, 16, 32, 64 µg/L) to produce plasma concentrations below, equal and above the range of Human Therapeutic Plasma Concentrations (H(T)PCs). Fluoxetine and its metabolite, norfluoxetine, were quantified in the plasma of individual fish and linked to behavioural anxiety-related endpoints. The minimum drug plasma concentrations that elicited anxiolytic responses in fish were above the upper value of the H(T)PC range, whereas no effects were observed at plasma concentrations below the H(T)PCs. In vivo metabolism of fluoxetine in humans and fish was similar, and displayed bi-phasic concentration-dependent kinetics driven by the auto-inhibitory dynamics and saturation of the enzymes that convert fluoxetine into norfluoxetine. The sensitivity of fish to fluoxetine was not so dissimilar from that of patients affected by general anxiety disorders. These results represent the first direct evidence of measured internal dose response effect of a pharmaceutical in fish, hence validating the Read-Across hypothesis applied to fluoxetine. Overall, this study demonstrates that the qCSE approach, anchored to internal drug concentrations, is a powerful tool to guide the assessment of the sensitivity of fish to pharmaceuticals, and strengthens the translational power of the cross-species extrapolation.
first_indexed 2024-04-12T18:28:51Z
format Article
id doaj.art-16ae92bc13f44f1790197ce3fc353461
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T18:28:51Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-16ae92bc13f44f1790197ce3fc3534612022-12-22T03:21:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e11046710.1371/journal.pone.0110467Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.Luigi Margiotta-CasaluciStewart F OwenRob I CummingAnna de PoloMatthew J WinterGrace H PanterMariann Rand-WeaverJohn P SumpterFish are an important model for the pharmacological and toxicological characterization of human pharmaceuticals in drug discovery, drug safety assessment and environmental toxicology. However, do fish respond to pharmaceuticals as humans do? To address this question, we provide a novel quantitative cross-species extrapolation approach (qCSE) based on the hypothesis that similar plasma concentrations of pharmaceuticals cause comparable target-mediated effects in both humans and fish at similar level of biological organization (Read-Across Hypothesis). To validate this hypothesis, the behavioural effects of the anti-depressant drug fluoxetine on the fish model fathead minnow (Pimephales promelas) were used as test case. Fish were exposed for 28 days to a range of measured water concentrations of fluoxetine (0.1, 1.0, 8.0, 16, 32, 64 µg/L) to produce plasma concentrations below, equal and above the range of Human Therapeutic Plasma Concentrations (H(T)PCs). Fluoxetine and its metabolite, norfluoxetine, were quantified in the plasma of individual fish and linked to behavioural anxiety-related endpoints. The minimum drug plasma concentrations that elicited anxiolytic responses in fish were above the upper value of the H(T)PC range, whereas no effects were observed at plasma concentrations below the H(T)PCs. In vivo metabolism of fluoxetine in humans and fish was similar, and displayed bi-phasic concentration-dependent kinetics driven by the auto-inhibitory dynamics and saturation of the enzymes that convert fluoxetine into norfluoxetine. The sensitivity of fish to fluoxetine was not so dissimilar from that of patients affected by general anxiety disorders. These results represent the first direct evidence of measured internal dose response effect of a pharmaceutical in fish, hence validating the Read-Across hypothesis applied to fluoxetine. Overall, this study demonstrates that the qCSE approach, anchored to internal drug concentrations, is a powerful tool to guide the assessment of the sensitivity of fish to pharmaceuticals, and strengthens the translational power of the cross-species extrapolation.http://europepmc.org/articles/PMC4206295?pdf=render
spellingShingle Luigi Margiotta-Casaluci
Stewart F Owen
Rob I Cumming
Anna de Polo
Matthew J Winter
Grace H Panter
Mariann Rand-Weaver
John P Sumpter
Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
PLoS ONE
title Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
title_full Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
title_fullStr Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
title_full_unstemmed Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
title_short Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
title_sort quantitative cross species extrapolation between humans and fish the case of the anti depressant fluoxetine
url http://europepmc.org/articles/PMC4206295?pdf=render
work_keys_str_mv AT luigimargiottacasaluci quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT stewartfowen quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT robicumming quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT annadepolo quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT matthewjwinter quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT gracehpanter quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT mariannrandweaver quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine
AT johnpsumpter quantitativecrossspeciesextrapolationbetweenhumansandfishthecaseoftheantidepressantfluoxetine